MétaCan
Menu
← Back to cohort
Record W4414670488 · doi:10.1136/bmjopen-2025-100560

Quadrivalent HPV Vaccine Evaluation Study with Addition of the Nonavalent Vaccine (QUEST-ADVANCE): protocol of an observational cohort study

2025· article· en· W4414670488 on OpenAlexafffundabout
Marit Middeldorp, Robine Donken, Aarthi Nirmal, Brenda M. Smith, Ana Márquez, Julie A. Bettinger, Marc Brisson, Ann N. Burchell, Simon R. Dobson, Meena Dawar, Eduardo L. Franco, Troy Grennan, Mel Krajden, Marie‐Hélène Mayrand, Shelly McNeil, Monika Naus, Chantal Sauvageau, Joel Singer, Laurie Smith, Gina Ogilvie, Manish Sadarangani

Bibliographic record

VenueBMJ Open · 2025
Typearticle
Languageen
FieldMedicine
TopicCervical Cancer and HPV Research
Canadian institutionsInstitut National de Santé Publique du QuébecDalhousie UniversityMcGill UniversityCentre hospitalier universitaire de QuébecVancouver Coastal HealthBC Centre for Disease ControlCentre for Advancing Health OutcomesSt. Michael's HospitalCentre Hospitalier de l’Université de MontréalBC Children's HospitalUniversité LavalUniversity of British ColumbiaBC Cancer AgencyUniversity of TorontoWomen's Health Research Institute
FundersCanadian Institutes of Health ResearchMichael Smith Health Research BCBC Children's HospitalChildren's Hospital Foundation
KeywordsObservational studyCohort studyProtocol (science)Informed consentResearch ethicsInstitutional review boardPublic healthHuman papillomavirus

Abstract

fetched live from OpenAlex

INTRODUCTION: The Quadrivalent human papillomavirus (HPV) Vaccine Evaluation Study with Addition of the Nonavalent Vaccine Study (QUEST-ADVANCE) aims to provide insight into the long-term immunogenicity and effectiveness of one, two and three HPV vaccine doses. Here, we describe the protocol for QUEST-ADVANCE. METHODS AND ANALYSIS: QUEST-ADVANCE is an observational cohort study including males and females who are unvaccinated or vaccinated with the quadrivalent or nonavalent HPV vaccine in British Columbia, Canada. Female participants who are unvaccinated or vaccinated with 1-3 doses of the quadrivalent or nonavalent HPV vaccine at 9-14 years of age will be recruited approximately 5 or 12 years postvaccination eligibility. Male participants who are unvaccinated or vaccinated with 1 or 2 doses of the nonavalent HPV vaccine at 9-14 years of age will be recruited at approximately 5 years postvaccination eligibility. The study involves a maximum of four visits over a period of 4-5 years for female participants, and two visits over a 12-month period for male participants. At each visit, self-collected swabs (cervico-vaginal or penile) and questionnaire data will be collected. In each study group, a subset of participants will be invited to participate in a substudy evaluating the long-term humoral immunogenicity of the HPV vaccine. Additional blood samples will be collected from participants who are part of the immunogenicity substudy. The total required sample size is 7180 individuals. The primary objectives are (1) to examine vaccine effectiveness in males and females against prevalent genital HPV infections for one, two and three doses of the HPV vaccine compared with unvaccinated participants and (2) to evaluate if there is non-inferior immunogenicity as indicated by type-specific antibody response of one dose of the HPV vaccine in 20-27-year-old females vaccinated at 9-14 years of age compared with historical data of three doses of the HPV vaccine females vaccinated at 16-26 years of age up to 12 years postvaccination. ETHICS AND DISSEMINATION: QUEST-ADVANCE was approved by the Research Ethics Board of the University of British Columbia/Children's and Women's Health Centre of British Columbia (H20-02111). Individual electronic informed consent or assent will be obtained from each participant before any study-specific procedures are undertaken. Results will be published in an international peer-reviewed journal and on the study website.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.037
metaresearch head score (Gemma)0.022
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Protocol · Consensus signal: Protocol
Teacher disagreement score0.037
Threshold uncertainty score0.194

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0370.022
Meta-epidemiology (narrow)0.0040.003
Meta-epidemiology (broad)0.0040.002
Bibliometrics0.0020.003
Science and technology studies0.0040.002
Scholarly communication0.0020.003
Open science0.0040.002
Research integrity0.0040.004
Insufficient payload (model declined to judge)0.0220.011

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.168
GPT teacher head0.527
Teacher spread0.360 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreProtocol

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes3
Has abstractyes

Explore more

Same venueBMJ Open→Same topicCervical Cancer and HPV Research→French-language works237,207→